Mechanisms underlying TNF-alpha effects on agonist-mediated calcium homeostasis in human airway smooth muscle cells

Mechanisms underlying TNF-alpha effects on agonist-mediated calcium homeostasis in human airway smooth muscle cells
复制标题

DOI:
10.1152/ajplung.1997.273.5.l1020
复制
发表时间:
1997-11-01
影响因子:
4.9
通讯作者:
Panettieri, RA
Panettieri, RA
中科院分区:
医学2区
文献类型:
--
作者:
Amrani, Y;Krymskaya, V;Panettieri, RA

文献摘要

被引文献

相似文献

我们之前已经表明,肿瘤坏死因子(TNF)- α,一种参与哮喘的细胞因子,增强了培养的人气道平滑肌(ASM)细胞对支气管收缩剂的Ca2+反应性。在本研究中,我们研究了tnf - α调节ASM细胞对这些药物的反应的潜在机制。在携带fura 2的人ASM细胞中,tnf - α和白细胞介素(IL)-1 β显著增强凝血素和缓激素引起的细胞内Ca2+升高。在tnf α处理的细胞中,凝血酶和缓激素的Ca2+响应分别为350 +/- 14和573 +/- 93 nM,而未处理的细胞中分别为130 +/- 17和247 +/- 48 nM (P < 0.0001)。在IL-1 β处理的细胞中,Ca2+对缓激肽的反应为350 +/- 21 nM,而未处理的细胞为127 +/- 12 nM (P < 0.0001)。tnf - α增强激动剂诱导的Ca2+反应的时间过程至少需要6小时,在孵育12小时后达到最大值。此外,环己亚胺,一种蛋白质合成抑制剂,完全阻断了tnf - α对Ca2+信号的增强作用。我们还发现,tnf - α显著增强了缓激素诱导的磷酸肌肽(PI)积累的增加。在3 × 10(-9)至3 × 10(-6) M缓激素作用下,对照细胞中PI积累的变化百分比为115 +/- 8至210 +/- 15%,而在tnf α处理的细胞中,PI积累的变化百分比为128 +/- 10至437 +/- 92%。PI转化为10mm NaF (G蛋白的直接激活剂)也被发现被tnf - α增强。与对照组相比,PI积累的变化百分比从对照细胞的280 +/- 35%增加到tnf - α处理细胞的437 +/- 92%。综上所述,这些结果表明tnf - α可以通过激活依赖于蛋白质合成的途径,有效调节ASM细胞中G蛋白介导的信号转导。我们的研究揭示了细胞因子在人ASM细胞中诱导Ca2+对支气管收缩剂反应增强的一种潜在机制。
We have previously shown that tumor necrosis factor (TNF)-alpha, a cytokine involved in asthma, enhances Ca2+ responsiveness to bronchoconstrictor agents in cultured human airway smooth muscle (ASM) cells. In the present study we investigated the potential mechanism(s) by which TNF-alpha modulates ASM cell responsiveness to such agents. In human ASM cells loaded with fura 2, TNF-alpha and interleukin (IL)-1 beta significantly enhanced thrombin-and bradykinin-evoked elevations of intracellular Ca2+. In TNF-alpha-treated cells, Ca2+ responses to thrombin and bradykinin were 350 +/- 14 and 573 +/- 93 nM vs. 130 +/- 17 and 247 +/- 48 nM in nontreated cells, respectively (P < 0.0001). In IL-1 beta-treated cells, the Ca2+ response to bradykinin was 350 +/- 21 vs. 127 +/- 12 nM in nontreated cells (P < 0.0001). The time course for TNF-alpha potentiation of agonist-induced Ca2+ responses requires a minimum of 6 h and was maximum after 12 h of incubation. In addition, cycloheximide, a protein synthesis inhibitor, completely blocked the potentiating effect of TNF-alpha on Ca2+ signals. We also found that TNF-alpha significantly enhanced increases in phosphoinositide (PI) accumulation induced by bradykinin. The percentage ofchange in PI accumulation over control was 115 +/- 8 to 210 +/- 15% in control cells vs. 128 +/- 10 to 437 +/- 92% in TNF-alpha-treated cells for 3 x 10(-9) to 3 x 10(-6) M bradykinin. The PI turnover to 10 mM NaF, a direct activator of G proteins, was also found to be enhanced by TNF-alpha. The percentage of change in PI accumulation over control increased from 280 +/- 35% in control cells to 437 +/- 92% in TNF-alpha-treated cells. Taken together, these results show that TNF-alpha can potently regulate G protein-mediated signal transduction in ASM cells by activating pathways dependent on protein synthesis. Our study demonstrates one potential mechanism underlying the enhanced Ca2+ response to bronchoconstrictor agents induced by cytokines in human ASM cells.